Home › Trial NCT06594445
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
- Trial IDNCT06594445
- StatusRecruiting
- PhasePhase 1
- Study typeInterventional
- SponsorMasonic Cancer Center, University of Minnesota
- Enrollment45
- Start date2024-11-19
- ConditionsMyeloid Malignancy · Acute Myeloid Leukemia · Myelodysplastic Syndromes
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.